Law

Here We Go Again: The Fosamax Preemption Saga Continues

For the second time, the U.S. Court of Appeals for the Third Circuit vacated the U.S. District Court for the District of New Jersey’s judgment that plaintiffs’ state law failure-to-warn claims in the ...
Health Affairs

Fosamax Lawsuit: The Importance Of State Duties To Warn Of Drug Dangers

In the United States, the safety of prescription drugs is overseen along two parallel pathways. Federal regulation is provided by the Food and Drug Administration (FDA), which works to ensure the ...
JD Supra

U.S. Third Circuit Rejects Claims of Preemption and Allows Fosamax Cases to Proceed

In 2022, over 500 plaintiffs filed a case alleging that Merck Sharp & Dohme Corp., a drug manufacturing company, failed to provide adequate warnings that one of their drugs increased the risk of ...
Law

Hundreds of Revived Fosamax Lawsuits Allowed to Move Forward as U.S. High Court Denies Merck's Bid for Appeal

The U.S. Supreme Court on Monday denied a petition for a writ of certiorari filed by the drug company Merck Sharp & Dohme Corp., bringing to a close a decade-long legal battle that had stalled ...
Reuters

Merck agrees to proposed $27.7 mln settlement over Fosamax lawsuits

NEW YORK, Dec 9 (Reuters) - Merck & Co Inc said on Monday that it was prepared to pay $27.7 million to settle lawsuits by hundreds of people who sued the company over allegations that its osteoporosis ...